Bendamustine Plus Rituximab Versus Fludarabine Plus Rituximab

Clinical trial NCT01456351 · COMPLETED

Trial details

NCT number: NCT01456351
Sponsor: University of Giessen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma Mantle Cell Lymphoma

Start date: 2003-09-01
Primary completion: 2010-08-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.